Reduction of microemulsion propofol-induced injection pain via target-controlled remifentanil infusion

Y-J Chae1, S-K Min, S-K Park

  • 1Department of Anaesthesiology and Pain Medicine, Ajou University School of Medicine, Suwon, Republic of Korea.

Insights

Remifentanil pretreatment effectively reduces pain from microemulsion propofol anesthesia injection. A target concentration of 4 ng/ml is recommended to minimize injection pain and complications.

Area of Science:

  • Anesthesiology
  • Pharmacology

Background:

  • Intravenous microemulsion propofol causes significant injection pain compared to lipid emulsion formulations.
  • Managing propofol injection pain is crucial for patient comfort during anesthesia induction.

Purpose of the Study:

  • To evaluate the efficacy of different target effect-site concentrations of remifentanil in preventing pain associated with microemulsion propofol injection.
  • To determine the optimal remifentanil concentration for mitigating propofol injection pain.

Main Methods:

  • A randomized controlled trial involving 96 patients undergoing anesthesia induction.
  • Patients were assigned to receive remifentanil at target effect-site concentrations of 0 ng/ml (control), 4 ng/ml, or 6 ng/ml prior to microemulsion propofol administration.

Main Results:

  • Remifentanil pretreatment significantly reduced both the incidence and severity of injection pain compared to the control group.
  • No significant difference in pain reduction was observed between the 4 ng/ml and 6 ng/ml remifentanil groups.
  • The 6 ng/ml remifentanil group showed a higher rate of complications than the 4 ng/ml group.

Conclusions:

  • Pre-administration of remifentanil at a target effect-site concentration of 4 ng/ml is an effective strategy to decrease microemulsion propofol injection pain.
  • A remifentanil concentration of 4 ng/ml appears to be a favorable balance between efficacy and safety for managing propofol injection pain.

Related Concept Videos

Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia01:16

Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia

Intravenous regional anesthesia or the Bier block technique is used to anesthetize a specific limb or extremity. It uses exsanguinated or blood-drained vessels to transport local anesthetics or LAs to the peripheral nerve trunks. Lidocaine without vasoconstrictors like epinephrine is most commonly used for this technique. Other drugs used are prilocaine, ropivacaine, and chloroprocaine. Bupivacaine is not recommended for this technique due to its high cardiac toxicity.
One of the advantages of...